Clinical trials
Expanded access trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Approved for marketing | 8 |
| No longer available | 6 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Bayer | 2 |
| Tibotec Pharmaceuticals, Ireland | 2 |
| Aragon Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Novartis | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Prostatic Neoplasms | 2 |
| Blast Crisis | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Colorectal Neoplasms | 1 |
| Dermatitis, Atopic | 1 |
| Eczema | 1 |
| Gastrointestinal Neoplasms | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.